Auna SA

Auna SA(AUNA)股票分析

$4.990

-0.164 (-3.29%)收盤時

Loading chart…
最高
5.160
開盤
5.130
成交量加權均價
5.03
成交量
271.87K
市值
—
最低
4.930
成交金額
1.37M
企業價值/稅息折舊攤銷前利潤(TTM)
4.04

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia.

AI 分析 of Auna SA (AUNA)

持有

Auna SA is currently not a strong buy due to mixed financial indicators and market sentiment. The current price is $5.16, with an RSI of 43.38 indicating potential weakness. Although there was a 9% year-over-year revenue growth reported, the adjusted EBITDA declined by 9% and the net income for Q2 2026 was only $6.5 million, showing volatility in profitability. The main risk is the recent downgrade by analysts, which reflects concerns over the company's financial performance and future earnings potential.

估值指標

Auna SA(AUNA)目前預期本益比為 0.00,5 年平均預期本益比為 9.07。

預期本益比

嚴重低估
5 年均值 P/E
9.07
目前P/E
0.00
高估
11.35
低估
6.78

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
5.03
目前EV/EBITDA
4.04
高估
5.64
低估
4.43

預期股價營收比

低估
5 年均值 P/S
0.30
目前P/S
0.07
高估
0.47
低估
0.13

事件時間軸

2026-10-22 (ET)

08:30:00

Company Expects Full-Year 2026 Revenue Growth in Line with Guidance

2026-10-21 (ET)

09:00:00

Auna Begins Construction Under PPP Agreement with EsSalud

2026-10-15 (ET)

09:00:00

Healthcare Services Company Reports Preliminary Q3 Data

2026-04-17 (ET)

08:50:00

Healthcare Services Peru Reports 4,855 Surgeries

2026-03-11 (ET)

12:00:00

Dow Jones Drops Over 400 Points Amid Oil Price Volatility

資訊

AUNA 常見問題 —— 由 Alphio AI 解答

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia. It operates in the Healthcare sector.

Auna SA is currently not a strong buy due to mixed financial indicators and market sentiment. The current price is $5.16, with an RSI of 43.38 indicating potential weakness. Although there was a 9% year-over-year revenue growth reported, the adjusted EBITDA declined by 9% and the net income for Q2 2026 was only $6.5 million, showing volatility in profitability. The main risk is the recent downgrade by analysts, which reflects concerns over the company's financial performance and future earnings potential.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易